Hernández-Castañeda Yazmin, Juárez-Melchor Daniela, Vera-Loaiza Aurea, Pérez-Arzola Alan Alberto, Crisanto-López Israel Enrique, Rodríguez-Hurtado Pablo Omar
Instituto Mexicano del Seguro Social, Hospital General de Zona No. 20, Servicio de Genética Médica. Puebla, Puebla, México.
Rev Med Inst Mex Seguro Soc. 2025 Mar 3;63(2):e6419. doi: 10.5281/zenodo.14616948.
Neurocutaneous syndromes are a group of genetic diseases that affect the skin, eyes, central and peripheral nervous systems. They include Neurofibromatosis type 1 (NF1), Tuberous sclerosis (TS), Von-Hippel Lindau disease, Neurofibromatosis type 2 (NF2), Ataxia Telangiectasia (AT) and Hypomelanosis of Ito.
To characterize the most frequent clinical manifestations in Neurocutaneous syndromes.
A descriptive, observational, cross-sectional and ambivalent study was carried out in the Genetics service of the General Hospital of Zone No. 20. Patients diagnosed with any neurocutaneous syndrome of any age were included and agreed to participate in the study.
Thirty-nine patients were reviewed, 21 patients (53.8%) were women and 18 (46.2%) were men. The median age of the patients was 12 years, with an interquartile range (25th-75th percentiles) of 6 and 17 years, respectively. The most frequent neurocutaneous syndromes were NF1 (62%) and ET (18%). All patients presented cutaneous manifestations, and 16 patients (42.1%) presented at least one neurological manifestation.
The timely interpretation of skin changes as primary lesions becomes a valuable instrument for the early identification of any neurological alteration; likewise, the search for skin changes should be carried out in all patients undergoing initial study for neurological manifestations.
神经皮肤综合征是一组影响皮肤、眼睛、中枢和周围神经系统的遗传性疾病。它们包括1型神经纤维瘤病(NF1)、结节性硬化症(TS)、冯·希佩尔·林道病、2型神经纤维瘤病(NF2)、共济失调毛细血管扩张症(AT)和伊藤色素减退症。
描述神经皮肤综合征最常见的临床表现。
在第20区综合医院的遗传学服务部门进行了一项描述性、观察性、横断面和双盲研究。纳入任何年龄被诊断患有任何神经皮肤综合征且同意参与研究的患者。
共审查了39例患者,其中21例(53.8%)为女性,18例(46.2%)为男性。患者的中位年龄为12岁,四分位间距(第25-75百分位数)分别为6岁和17岁。最常见的神经皮肤综合征是NF1(62%)和ET(18%)。所有患者均有皮肤表现,16例(42.1%)患者至少有1种神经学表现。
将皮肤变化及时解读为原发性病变成为早期识别任何神经学改变的重要手段;同样,对于所有因神经学表现接受初步检查的患者,都应进行皮肤变化的检查。